Trevisani, F.; Di Marco, F.; Floris, M.; Pani, A.; Minnei, R.; Scartozzi, M.; Cirillo, A.; Gelibter, A.; Botticelli, A.; Rijavec, E.;
et al. Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario. Vaccines 2022, 10, 679.
https://doi.org/10.3390/vaccines10050679
AMA Style
Trevisani F, Di Marco F, Floris M, Pani A, Minnei R, Scartozzi M, Cirillo A, Gelibter A, Botticelli A, Rijavec E,
et al. Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario. Vaccines. 2022; 10(5):679.
https://doi.org/10.3390/vaccines10050679
Chicago/Turabian Style
Trevisani, Francesco, Federico Di Marco, Matteo Floris, Antonello Pani, Roberto Minnei, Mario Scartozzi, Alessio Cirillo, Alain Gelibter, Andrea Botticelli, Erika Rijavec,
and et al. 2022. "Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario" Vaccines 10, no. 5: 679.
https://doi.org/10.3390/vaccines10050679
APA Style
Trevisani, F., Di Marco, F., Floris, M., Pani, A., Minnei, R., Scartozzi, M., Cirillo, A., Gelibter, A., Botticelli, A., Rijavec, E., Cattaneo, M., Garrone, O., & Ghidini, M.
(2022). Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario. Vaccines, 10(5), 679.
https://doi.org/10.3390/vaccines10050679
